Characterising lipoteichoic acid as an in vitro model of acute neuroinflammation

Int Immunopharmacol. 2020 Aug:85:106619. doi: 10.1016/j.intimp.2020.106619. Epub 2020 May 30.

Abstract

Toll-like receptor 2 (TLR2) is a primary sensor for pathogens, including those derived from gram-positive bacteria. It can also mediate the effects of endogenous inflammatory signals such as β-amyloid peptide (Aβ), thus promoting the microglial activation and subsequent neuronal dysfunction, characteristic of chronic neuroinflammatory conditions. More recently, a role for TLR2 has been proposed in the pathogenesis of disorders associated with acute inflammation, including anxiety and depression. The current study aims to characterise the acute effects of the TLR2 agonist lipoteichoic acid (LTA) on microglial activation and neuronal integrity, and to evaluate the influence of LTA exposure on sensitivity to the inflammation and neuronal dysfunction associated with Aβ. Using BV2 and N2a cells as an in vitro model, we highlight that acute exposure to LTA robustly promotes inflammatory cytokine and nitric oxide (NO) production in microglia but also in neurons, similar to that reported under longer-term and chronic inflammatory conditions. Moreover, we find that exposure to LTA can enhance sensitivity to subthreshold Aβ, promoting an 'M1'-like phenotype in microglia and provoking dysregulation of neuronal activity in acute hippocampal slices. Anti-inflammatory agents, including mimetics of brain-derived neurotrophic factor (BDNF), have proven effective at alleviating chronic neuroinflammatory complications. We further examined the effects of 7,8,3-trihydroxyflavone (7,8,3-THF), a small-molecule TrkB agonist, on LTA-induced microglial activation. We report that 7,8,3-THF can significantly ameliorate interleukin (IL)-6 and NO production in LTA-stimulated BV2 cells. Taken together, our findings offer support for exploration of TLR2 as a potential target for therapeutic intervention into acute neuroinflammatory conditions. Moreover we propose that exposure to gram-positive bacterial pathogens may promote sensitivity to the inflammatory changes characteristic of the aged brain.

Keywords: BDNF, 7,8,3-THF; BV2; Cytokines; Hippocampus; Nitric oxide; TLR2; β-amyloid.

MeSH terms

  • Acute Disease
  • Amyloid beta-Peptides / toxicity
  • Animals
  • Cell Line
  • Cyclooxygenase 2 / metabolism
  • Cytokines / metabolism
  • Flavones / pharmacology
  • Inflammation / chemically induced
  • Inflammation / metabolism*
  • Inflammation / physiopathology*
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Lipopolysaccharides / toxicity*
  • Male
  • Mice, Inbred C57BL
  • Microglia / metabolism
  • Models, Theoretical
  • Nervous System Diseases / chemically induced
  • Nervous System Diseases / metabolism*
  • Nervous System Diseases / physiopathology*
  • Neurons / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Nitrites / metabolism
  • Receptor, trkB / agonists
  • Teichoic Acids / toxicity*
  • Toll-Like Receptor 2 / agonists*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • 7,8,3'-trihydroxyflavone
  • Amyloid beta-Peptides
  • Cytokines
  • Flavones
  • IL1B protein, mouse
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • Nitrites
  • Teichoic Acids
  • Tnf protein, mouse
  • Toll-Like Receptor 2
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • Nitric Oxide
  • lipoteichoic acid
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Receptor, trkB